Polaris Partners
Overview
Polaris Partners has a 20+ year history of partnering with entrepreneurs and innovators improving the way we live and work.
Investment Focus
- Innovative healthcare or biotechnology companies
- Strong management teams
- Scalable business models
- Innovative technology solutions
- Clear market differentiation
- Potential for significant impact
Portfolio Companies
Reach Polaris Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Polaris Partners
What sectors does Polaris Partners invest in?
Polaris Partners invests in Financial Services, Technology, Healthcare, Energy, Real Estate and Telecommunications, and is based in Boston, Massachusetts, United States. Polaris Partners is listed as a vc in the ConnectSafely investor database.
What stage does Polaris Partners invest at?
Polaris Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Polaris Partners invest in?
Polaris Partners invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Polaris Partners?
Team members listed for Polaris Partners include Harold Friedman (Chief Financial Officer) and Brian Chee (Managing Partner).
What companies has Polaris Partners invested in?
Polaris Partners's portfolio includes Ginkgo Bioworks, Foundation Medicine, Biogen, Alnylam Pharmaceuticals, T2 Biosystems, Kura Oncology, CureMetrix and Mersana Therapeutics.
How do I contact Polaris Partners?
Polaris Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
